Prescriptions Plus Inc Now Offering Prescription Topical Pain Creams for Migraine Headache Relief Nationwide
Wellington, Florida (PRWEB) June 30, 2014 -- The top prescription pain cream company, Prescriptions Plus Inc, is now offering migraine headache relief creams nationwide. Due to exceptional results, Prescriptions Plus Inc has added the condition to the acceptable list of conditions for which creams are prescribed. The migraine creams are provided with a telemedicine consultation and shipped directly to the patient’s home. Call (888) 998-6343 for more information and an immediate consultation.
With migraine headaches affecting over 10% of the US population, they are a significant health problem in need of effective treatment options. Prescriptions Plus Inc is now offering their custom formulated pain creams nationwide for those suffering from migraines, with exceptional relief being seen in the majority of patients.
The prescription pain creams are provided after a short telemedicine consultation with a licensed doctor for those with private insurance and prescription benefits. The prescription creams are then formulated and shipped directly to the patient.
A nationwide survey by the Patient Outcomes Analysis looked at thousands of patients using prescription pain creams for all types of conditions including migraine headaches. Over 80% of patient achieved excellent pain relief. The creams are simple to apply, work quickly, and very minimal of the ingredients get into the bloodstream. Therefore, no drug interactions occur and there is no chance for addiction.
In addition to offering creams for migraine headaches, Prescriptions Plus Inc now offers the topical pain creams for arthritis, tendonitis, post surgical, sports injuries and scar removal as well.
For those with private insurance and prescription benefits who would like more information and to schedule an immediate telemedicine consultation, call (888) 998-6343.
Jon, Prescriptions Plus, http://prescriptionpainreliefcream.com/, +1 (888) 998-6343, [email protected]
Share this article